The Government’s new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT) products comes into effect from tomorrow (1 April 2023). PSNC has been in discussion with the British Medical Association (BMA) about the impact of the new HRT PPC on working practices. Both we and the BMA are agreed on the importance of collaborative
Read moreYouGov polling commissioned by PSNC has shown the strength of public support for pharmacies and for a Pharmacy First service. The results show the extent of the public backing for a Pharmacy First approach – PSNC has been arguing that a fully-funded service would be beneficial for pharmacies, patients and the wider NHS. And they
Read moreClass 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) Drug alert number: EL (23)A/13 Date issued: 30 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Briviact 75 mg film-coated tablets, PLPI 18716/0146 SNOMED Code: 37622711000001100 Batch number Expiry date
Read moreThe Department of Health and Social Care (DHSC) has today (30/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.96 Cefalexin 250mg tablets 28 £2.86 Cefalexin 500mg capsules 21 £2.80 Cefalexin 500mg tablets 21 £2.80 Cinnarizine 15mg tablets 84 £5.70 Clarithromycin 125mg/5ml oral suspension 70
Read moreFollowing applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 25 new products were classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 April 2023. This took the total number of products granted DND status to over 600 products following checks
Read moreFollowing representations from PSNC, the Department of Health of Social Care (DHSC) has re-determined the special container status of Colesevelam 625mg tablets. From April 2023, the listing in Part VIII of the Drug Tariff has been updated to reflect the change in special container status as it meets the relevant criteria as set out in Part
Read moreNHS England has announced that the way some Community Pharmacist Consultation Service (CPCS) GP referrals are sent by the EMIS PharmRefer product is changing. From 29th March 2023 (today), community pharmacies using CPCS solutions from Cegedim Healthcare Solutions, Positive Solutions or Sonar Informatics won’t access those GP CPCS referrals through PharmOutcomes. Instead, referrals from GPs
Read morePSNC’s factsheet for community pharmacy teams explains how to access the shared NHSmail inbox within the Outlook mobile app. The app enables contractors to quickly and easily access NHSmail and provides contractors with the flexibility to choose how and when they would like to be notified about incoming emails. The short one-page factsheet provides a
Read moreFollowing the Government decisions to increase in the NHS prescription charge and introduce a HRT prescription prepayment certificate from 1st April 2023, PSNC has designed two posters that can be displayed in community pharmacies. PSNC’s Prescription Charge Card confirms the new NHS prescription charge of £9.65 per item, explaining that this is a tax from the Government
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Ciclosporin (Vanquorel®) 25mg capsules. MSN/2023/036 Tier 3 – high impact Date of issue 29th March 2023 Ciclosporin (Vanquorel®) 25mg capsules are out of stock until mid-May 2023. Alternative brands of ciclosporin capsules (Neoral® and Capsorin®) remain available and can support an
Read more
